重组小鼠CD33(Siglec-3)北京厂家

特别提示：包括重组小鼠CD33(Siglec-3)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组小鼠CD33(Siglec-3)
英文名称：Recombinant Mouse Sialic Acid Binding Ig-like Lectin 3
产品货号：JN1892
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Asp18-Glu240在C端含有His标签。

CD33/Siglec-3质量控制：＞95%(还原性SDS-PAGE)

CD33/Siglec-3制剂：冻干品

CD33/Siglec-3保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

CD33/Siglec-3复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于CD33/Siglec-3：
Mouse myeloid cell surface antigen CD33(CD33) is a member of the immunoglobulin superfamily and SIGLEC (sialic acid binding Ig-like lectin) family. CD33 contains one Ig-like C2-type domain and one Ig-like V-type domain. CD33 is a putative adhesion molecule of myelomonocytic-derived cells that mediates sialic-acid dependent binding to cells. CD33 preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, CD33 may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. CD33 induces apoptosis in acute myeloid leukemia. CD33 is becoming increasingly important as a target of antibody-mediated therapy in acute myeloid leukaemia (AML).

我公司销售的重组小鼠CD33(Siglec-3)北京厂家，Recombinant Mouse Sialic Acid Binding Ig-like Lectin 3，重组CD33，重组Sialic Acid Binding Ig-like Lectin 3，rCD33，重组小鼠Sialic Acid Binding Ig-like Lectin 3，重组小鼠Siglec-3，rSiglec-3，rmSiglec-3，重组小鼠CD33，rmCD33，重组Siglec-3质量上佳，价格普惠，欢迎广大新老客户踊跃订购。